Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood.

Xu H, Aguilar ZP, Yang L, Kuang M, Duan H, Xiong Y, Wei H, Wang A.

Biomaterials. 2011 Dec;32(36):9758-65. doi: 10.1016/j.biomaterials.2011.08.076. Epub 2011 Sep 14.

2.

Capture and detection of cancer cells in whole blood with magnetic-optical nanoovals.

Bhana S, Chaffin E, Wang Y, Mishra SR, Huang X.

Nanomedicine (Lond). 2014 Apr;9(5):593-606. doi: 10.2217/nnm.13.77. Epub 2013 Jun 14.

PMID:
23763633
3.

HER2/neu antibody conjugated poly(amino acid)-coated iron oxide nanoparticles for breast cancer MR imaging.

Yang HM, Park CW, Woo MA, Kim MI, Jo YM, Park HG, Kim JD.

Biomacromolecules. 2010 Nov 8;11(11):2866-72. doi: 10.1021/bm100560m. Epub 2010 Oct 8.

PMID:
20932000
4.

Folic acid conjugated magnetic iron oxide nanoparticles for nondestructive separation and detection of ovarian cancer cells from whole blood.

Liu W, Nie L, Li F, Aguilar ZP, Xu H, Xiong Y, Fu F, Xu H.

Biomater Sci. 2016 Jan;4(1):159-66. doi: 10.1039/c5bm00207a.

PMID:
26478922
6.

Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors.

Hathaway HJ, Butler KS, Adolphi NL, Lovato DM, Belfon R, Fegan D, Monson TC, Trujillo JE, Tessier TE, Bryant HC, Huber DL, Larson RS, Flynn ER.

Breast Cancer Res. 2011 Nov 3;13(5):R108. doi: 10.1186/bcr3050.

7.

Trastuzumab-conjugated liposome-coated fluorescent magnetic nanoparticles to target breast cancer.

Jang M, Yoon YI, Kwon YS, Yoon TJ, Lee HJ, Hwang SI, Yun BL, Kim SM.

Korean J Radiol. 2014 Jul-Aug;15(4):411-22. doi: 10.3348/kjr.2014.15.4.411. Epub 2014 Jul 9.

8.

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

Yang L, Peng XH, Wang YA, Wang X, Cao Z, Ni C, Karna P, Zhang X, Wood WC, Gao X, Nie S, Mao H.

Clin Cancer Res. 2009 Jul 15;15(14):4722-32. doi: 10.1158/1078-0432.CCR-08-3289. Epub 2009 Jul 7.

9.

In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes.

Ying E, Hwang HM.

Sci Total Environ. 2010 Sep 15;408(20):4475-81. doi: 10.1016/j.scitotenv.2010.07.025. Epub 2010 Aug 2.

PMID:
20673962
10.

Iron oxide nanoparticle assisted purification and mass spectrometry based proteolytic mapping of intact CD4+ T cells from human blood.

Mandal SM, Ghosh AK, Mandal M.

Prep Biochem Biotechnol. 2009;39(1):20-31. doi: 10.1080/10826060802589510.

PMID:
19090418
11.

Triple Therapy of HER2+ Cancer Using Radiolabeled Multifunctional Iron Oxide Nanoparticles and Alternating Magnetic Field.

Zolata H, Afarideh H, Davani FA.

Cancer Biother Radiopharm. 2016 Nov;31(9):324-329.

PMID:
27831759
12.

MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.

Funovics MA, Kapeller B, Hoeller C, Su HS, Kunstfeld R, Puig S, Macfelda K.

Magn Reson Imaging. 2004 Jul;22(6):843-50.

PMID:
15234453
13.

Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia.

Zhang J, Dewilde AH, Chinn P, Foreman A, Barry S, Kanne D, Braunhut SJ.

Int J Hyperthermia. 2011;27(7):682-97. doi: 10.3109/02656736.2011.609863.

PMID:
21992561
14.

Recyclable and stable silver deposited magnetic nanoparticles with poly (vinyl pyrrolidone)-catechol coated iron oxide for antimicrobial activity.

Mosaiab T, Jeong CJ, Shin GJ, Choi KH, Lee SK, Lee I, In I, Park SY.

Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):3786-94. doi: 10.1016/j.msec.2013.05.009. Epub 2013 May 12.

PMID:
23910278
15.

PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.

Lee HY, Li Z, Chen K, Hsu AR, Xu C, Xie J, Sun S, Chen X.

J Nucl Med. 2008 Aug;49(8):1371-9. doi: 10.2967/jnumed.108.051243. Epub 2008 Jul 16.

16.

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.

Gupta AK, Gupta M.

Biomaterials. 2005 Jun;26(18):3995-4021. Review.

PMID:
15626447
17.

Targeted antitumor efficacy and imaging via multifunctional nano-carrier conjugated with anti-HER2 trastuzumab.

Choi WI, Lee JH, Kim JY, Heo SU, Jeong YY, Kim YH, Tae G.

Nanomedicine. 2015 Feb;11(2):359-68. doi: 10.1016/j.nano.2014.09.009. Epub 2014 Sep 28.

PMID:
25262581
18.

Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay.

Li Q, Qi H, Zhou HX, Deng CY, Zhu H, Li JF, Wang XL, Li FR.

Int J Nanomedicine. 2011;6:2175-81. doi: 10.2147/IJN.S24731. Epub 2011 Sep 29.

19.

Stabilizing Alginate Confinement and Polymer Coating of CO-Releasing Molecules Supported on Iron Oxide Nanoparticles To Trigger the CO Release by Magnetic Heating.

Meyer H, Winkler F, Kunz P, Schmidt AM, Hamacher A, Kassack MU, Janiak C.

Inorg Chem. 2015 Dec 7;54(23):11236-46. doi: 10.1021/acs.inorgchem.5b01675. Epub 2015 Nov 23.

PMID:
26595858
20.

Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.

Kanazaki K, Sano K, Makino A, Shimizu Y, Yamauchi F, Ogawa S, Ding N, Yano T, Temma T, Ono M, Saji H.

Nanomedicine. 2015 Nov;11(8):2051-60. doi: 10.1016/j.nano.2015.07.007. Epub 2015 Jul 31.

PMID:
26238078

Supplemental Content

Support Center